MetaVia Inc. — Director's Dealing 2016

Oct 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2016-10-05

Reporting Person: Golden Lee Scott (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-05	Employee Stock Option (right to buy)	$10.8	A	126000	Acquired	2026-10-04	Common Stock (126000)	Direct

Footnotes

F1: The option vests as to 12,000 shares immediately on the Vesting Commencement Date; one-fourth of the remaining shares vest on the last day of the month on which the one year anniversary of the Vesting Commencement Date occurs; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the last day of the month on which the one year anniversary of the Vesting Commencement Date occurs.